Open AccessDo practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?
Author(s) -
Priscilla Albuquerque Pereira,
Aditya Kapoor,
Archana Sinha,
Surendra Kumar Agarwal,
Shantanu Pande,
Roopali Khanna,
Nilesh Srivastava,
Sudeep Kumar,
Naveen Garg,
Satyendra Tewari,
Pravin K. Goel
Publication year - 2017
Publication title -
indian journal of medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.578
H-Index - 87
ISSN - 0971-5916
DOI - 10.4103/ijmr.ijmr_1905_15
Subject(s) - medicine , conventional pci , cardiology , percutaneous coronary intervention , ejection fraction , medical prescription , angioplasty , clopidogrel , aspirin , angina , revascularization , coronary artery bypass surgery , myocardial infarction , artery , heart failure , pharmacology
Prescription patterns of guideline-directed medical therapy (GDMT) after coronary artery bypass surgery [coronary artery bypass graft (CABG)] and percutaneous coronary intervention (PCI) at hospital discharge are often not optimal. In view of scarce data from the developing world, a retrospective analysis of medication advice to patients following CABG and PCI was conducted.